产品名称

CC-401

产品货号

Axon 2025 CAS [395104-30-0] MF C22H24N6OMW 388.47 Purity: 99% Soluble in DMSO and Ethanol Description A second generation ATP-competitive c-Jun N terminal kinase (JNK) inhibitor with potential antineoplastic activity. Keywords: CC-401 | supplier | JNK inhibitor | CC401 | CC 401 | CAS [395104-30-0] | MAPK | MAPK (JNK) | Inhibitor | Enzymes

产品价格

现货询价，电话：010-67529703

产品规格

产品品牌

axonmedchem

产品概述

产品详情

CC-401

Based on 12 reference(s) in Google Scholar 9 10 12

Axon 2025

CAS [395104-30-0]

MF C22H24N6O
MW 388.47

Purity: 99%
Soluble in DMSO and Ethanol

CC-401

Description

A second generation ATP-competitive c-Jun N terminal kinase (JNK) inhibitor with potential antineoplastic activity.

Keywords: CC-401 | supplier | JNK inhibitor | CC401 | CC 401 | CAS [395104-30-0] | MAPK | MAPK (JNK) | Inhibitor | Enzymes

T Uehara et al. JNK mediates hepatic ischemia reperfusion injury. J. Hepatol. 2005, 42(6), 850-859.

FY Ma et al. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J. Am. Soc. Nephrol. 2007, 18(2), 472-484.

Apoptosis Cell Signaling & Oncology Immunology Pain & Inflammation MAPK (JNK) p53-Tumor Suppression NF-κB MAPK EC 2.7.11.24

ATP-competitive JNK inhibitor

Chemical name

3-(3-(2-(piperidin-1-yl)ethoxy)phenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole

Parent CAS No.

[395104-30-0]

产品资料